[Tanakan in the treatment of cognitive and autonomic impairments and headache in young patients]

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(6):38-41.
[Article in Russian]

Abstract

Objective: To determine the efficacy and tolerability of tanakan in the treatment of memory and attention impairments in young patients.

Material and methods: We studied 30 outpatients (24 women and 6 men, mean age 33,5±7,5 years) with headache, memory and attention impairments and decrease in mental working capacity. Treatment duration was 90 days. Patients received tanakan in dose 40 mg 3 times per day to restore cognitive function. The study design included 4 visits during which patients completed questionnaires and scales.

Results: All patients reported positive changes in mood, memory, information learning and working capacity. Headaches of tension decreased by 50%, vertigo and noise in ears became less intense, autonomic disturbances practically disappeared. No effect on the frequency of migrainous attacks was found.

Conclusion: Tanakan is effective and safe for symptomatic therapy of cognitive impairment in any age, including young patients.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Attention
  • Autonomic Nervous System Diseases / drug therapy*
  • Cognition Disorders / drug therapy*
  • Female
  • Headache Disorders / drug therapy*
  • Humans
  • Male
  • Memory Disorders / drug therapy*
  • Plant Extracts / therapeutic use*

Substances

  • Plant Extracts
  • Ginkgo biloba extract